Article (Scientific journals)
Response from the authors: As-needed ICS/formoterol or as-needed SABA in mild asthma?
Papi, Alberto; Ferreira, Diogenes S; Tonia, Thomy et al.
2024In European Respiratory Journal, 63 (4), p. 2400395
Peer Reviewed verified by ORBi
 

Files


Full Text
Eur Respir J-2024-response Papi schleich-2400395.pdf
Author postprint (326.01 kB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Formoterol Fumarate; Budesonide; Humans; Formoterol Fumarate/therapeutic use; Asthma/drug therapy; Asthma; Pulmonary and Respiratory Medicine
Disciplines :
General & internal medicine
Author, co-author :
Papi, Alberto ;  Respiratory Medicine, University of Ferrara, Ferrara, Italy ppa@unife.it ; Task force co-chairs
Ferreira, Diogenes S;  Private Practice, Allergy and Immunology, Belo Horizonte, Brazil ; Task force co-chairs
Tonia, Thomy;  Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland
Schleich, Florence  ;  Université de Liège - ULiège > Département des Sciences de l'activité physique et de la réadaptation ; Task force co-chairs
Language :
English
Title :
Response from the authors: As-needed ICS/formoterol or as-needed SABA in mild asthma?
Publication date :
April 2024
Journal title :
European Respiratory Journal
ISSN :
0903-1936
eISSN :
1399-3003
Publisher :
European Respiratory Society, England
Volume :
63
Issue :
4
Pages :
2400395
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 01 July 2025

Statistics


Number of views
30 (1 by ULiège)
Number of downloads
23 (1 by ULiège)

Scopus citations®
 
1
Scopus citations®
without self-citations
1
OpenCitations
 
0
OpenAlex citations
 
1

Bibliography


Similar publications



Contact ORBi